Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li + adducts

Journal of Mass Spectrometry

Volumn 42, Issue 5, 2007, Pages 598-620

  Bennion, Beau ^a   Dasgupta, Somsankar ^b   Hogan, Edward L ^c   Levery, Steven B ^a  

^a Univ of New Hampshire   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cerebroside; Electrospray ionization; Lithium; Myelin; Sphingolipid

Indexed keywords

CEREBROSIDE; MYELIN; SPHINGOID MOIETY; SPHINGOLIPID;

ACYLATION; AMIDES; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR DYNAMICS;

FATTY ACIDS;

3 O ACETYLSPHINGOSINE GALACTOSYLCERAMIDE DERIVATIVE; CERAMIDE DERIVATIVE; LITHIUM; UNCLASSIFIED DRUG;

ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BRAIN; CATIONS, MONOVALENT; CATTLE; GALACTOSYLCERAMIDES; LITHIUM; MYELIN SHEATH; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOSINE; TANDEM MASS SPECTROMETRY;

BOVINAE; RATTUS; SPHINGOIDEA;

EID: 34249287708     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1190     Document Type: Article

References (37)

1. Clausen H, Hakomori S. ABH and related histo-blood group antigens: immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989; 56: 1.
2. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim. Biophys. Acta 1999; 1473: 247.
3. Kanfer JN, Hakomori S. Sphingolipid Biochemistry. Plenum Press: New York, London, 1983.
4. Kolter T, Sandhoff K. Sphingolipids-their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angew. Chem., Int. Ed. Engl. 1999; 38: 1532.
5. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996; 56: 5309.
6. Hakomori S. Cancer-associated glycosphingolipid antigens: their structure, organization, and function. Acta Anat. 1998; 161: 79.
7. O'Brien JS, Sampson EL. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 1965; 6: 537.
8. Norton WT, Autilio LA. The lipid composition of purified bovine brain myelin. J. Neurochem. 1966; 13: 213.
9. Honke K, Zhang Y, Cheng X, Kotani N, Taniguchi N. Biological roles of sulfoglycolipids and pathophysiology of their deficiency. Glycoconjugate J. 2004; 21: 59.
10. Yates AJ. Gangliosides in the nervous system during development and regeneration. Neurochem. Pathol. 1986; 5: 309.
11. Norton WT, Brotz M. New galactolipids of brain: a monoalkyl-monoacyl- glyceryl galactoside and cerebroside fatty acid esters. Biochem. Biophys. Res. Commun. 1963; 12: 198.
12. Klenk E, Doss M. On the occurrence of N-stearyl-sphingosine-galactoside in the brain and its isolation. Hoppe-Seyler's Z. Physiol. Chem. 1965; 342: 187.
13. Tamai Y, Taketomi T, Yamakawa T. New glycolipids in bovine brain. Jpn. J. Exp. Med. 1967; 37: 79.
14. Levery SB, Nudelman ED, Hakomori S. Novel modification of glycosphingolipids by long-chain cyclic acetals: isolation and characterization of plasmalocerebroside from human brain. Biochemistry 1992; 31: 5335.
15. Nudelman ED, Levery SB, Igarashi Y, Hakomori S. Plasmalopsychosine: a novel plasmai (fatty aldehyde) conjugate of psychosine with cyclic acetal linkage. Isolation and characterization from human brain white matter. J. Biol. Chem. 1992; 267: 11007.
16. Dasgupta S, Levery SB, Hogan EL. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J. Lipid Res. 2002; 43: 751.
17. + ions. J. Am. Soc. Mass Spectrom. 1992; 3: 260.
18. Ann Q, Adams J. Structure-specific collision-induced fragmentations of ceramides cationized with alkali-metal ions. Anal. Chem. 1993; 65: 7.
19. Adams J, Ann Q. Structure determination of sphingolipids by mass spectrometry. Mass Spectrom. Rev. 1993; 12: 51.
20. Sullards MC, Schmelz E-M, Merrill AH Jr. Analysis of soybean and wheat glucosylceramides by tandem mass spectrometry. In Proceedings 46th ASMS Conference Mass Spectrometry Allied Topics, Orlando, FL, 1998; 661.
21. Duarte RS, Polycarpo CR, Wait R, Hartmann R, Bergter EB. Structural characterization of neutral glycosphingolipids from Fusarium species. Biochim. Biophys. Acta 1998; 1390: 186.
22. + adduct ions. Rapid Commun. Mass Spectrom. 2000; 14: 551.
23. Hsu FF, Turk J. Structural determination of sphingomyelin by tandem mass spectrometry with electrospray ionization. J. Am. Soc. Mass Spectrom. 2000; 11: 437.
24. Hsu FF, Turk J. Structural determination of glycosphingolipids as lithiated adducts by electrospray ionization mass spectrometry using low-energy collisional-activated dissociation on a triple stage quadrupole instrument. J. Am. Soc. Mass Spectrom. 2001; 12: 61.
25. Hsu FF, Turk J, Stewart ME, Downing DT. Structural studies on ceramides as lithiated adducts by low energy collisional-activated dissociation tandem mass spectrometry with electrospray ionization. J. Am. Soc. Mass Spectrom. 2002; 13: 680.
26. Olling A, Breimer ME, Peltomaa E, Samuelsson BE, Ghardashkhani S. Electrospray ionization and collision-induced dissociation time-of-flight mass spectrometry of neutral glycosphingolipids. Rapid Commun. Mass Spectrom. 1998; 12: 637.
27. + adduct ions. Rapid Commun. Mass Spectrom. 2001; 15: 2240.
28. Toledo MS, Levery SB, Glushka J, Straus AH, Takahashi HK. Structure elucidation of sphingolipids from the mycopathogen Sporothrix schenckii: identification of novel glycosylinositol phosphorylceramides with core Manal-6Ins linkage. Biochem. Biophys. Res. Commun. 2001; 280: 19.
29. Toledo MS, Levery SB, Straus AH, Takahashi HK. Sphingolipids of the mycopathogen Sporothrix schenckii: identification of a glycosylinositol phosphorylceramide novel core GlcNH2 α1-2Ins motif. FEBS Lett. 2001; 493: 50.
30. Bennion B, Park C, Fuller M, Lindsey R, Momany M, Jennemann R, Levery SB. Glycosphingolipids of the model fungus Aspergillus nidulans: characterization of GIPCs with oligo-α-mannose-type glycans. J. Lipid Res. 2003; 44: 2073.
31. Domon B, Costello CE. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 1988; 27: 1534.
32. Domon B, Vath JE, Costello CE. Analysis of derivatized ceramides and neutral glycosphingolipids by high-performance tandem mass spectrometry. Anal. Biochem. 1990; 184: 151.
33. Costello CE, Vath JE. Tandem mass spectrometry of glycolipids. Methods Enzymol. 1990; 193: 738.
34. Gu M, Kerwin JL, Watts JD, Aebersold R. Ceramide profiling of complex lipid mixtures by electrospray ionization mass spectrometry. Anal. Biochem. 1997; 244: 347.
35. Sullards MC. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. Methods Enzymol. 2000; 312: 32.
36. Sullards MC, Merrill AH Jr. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE 2001; 2001: L1.
37. Dasgupta S, Everhart MB, Bhat NR, Hogan EL. Neutral monoglycosylceramides in rat brain: occurrence, molecular expression and developmental variation. Dev. Neurosci. 1997; 19: 152.